21,300 Shares in Healthpeak Properties, Inc. $DOC Acquired by Alan B Lancz & Associates Inc.

Key Points

• Alan B Lancz & Associates Inc. has acquired 21,300 shares of Healthpeak Properties, Inc. valued at approximately $373,000, marking a significant new position for the firm.
• Healthpeak Properties recently declared a monthly dividend of $0.1017, representing an annualized yield of 6.6%, with the payout ratio currently at 508.33%.
• As of recent reports, Healthpeak Properties has a consensus rating of "Moderate Buy" with a target price of $21.33, amidst various analyst ratings and updates.

Alan B Lancz & Associates Inc. acquired a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 21,300 shares of the real estate investment trust's stock, valued at approximately $373,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. TCTC Holdings LLC boosted its holdings in shares of Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after buying an additional 751 shares during the last quarter. Brooklyn Investment Group boosted its holdings in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock worth $27,000 after buying an additional 873 shares during the last quarter. S.A. Mason LLC boosted its holdings in shares of Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares during the last quarter. Dagco Inc. purchased a new position in Healthpeak Properties during the first quarter valued at approximately $30,000. Finally, GKV Capital Management Co. Inc. purchased a new position in Healthpeak Properties during the first quarter valued at approximately $36,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 1,490 shares of Healthpeak Properties stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the transaction, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have acquired a total of 8,783 shares of company stock valued at $150,129 in the last quarter. Insiders own 0.23% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Healthpeak Properties in a report on Wednesday, October 8th. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Evercore ISI set a $22.00 price target on shares of Healthpeak Properties in a report on Monday, September 15th. Raymond James Financial raised shares of Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Monday, September 15th. Finally, Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 27th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus target price of $21.33.

Healthpeak Properties Trading Up 0.5%

Healthpeak Properties stock opened at $18.55 on Monday. The stock has a market cap of $12.89 billion, a P/E ratio of 77.27, a PEG ratio of 3.16 and a beta of 1.09. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties, Inc. has a 1 year low of $16.63 and a 1 year high of $23.26. The firm's 50 day moving average price is $18.16 and its 200-day moving average price is $17.89.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company's revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter last year, the business posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, equities analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be given a $0.1017 dividend. This represents a c) annualized dividend and a yield of 6.6%. The ex-dividend date is Friday, December 19th. Healthpeak Properties's payout ratio is currently 508.33%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.